Navigation Links
AMP celebrates SCOTUS decision on AMP v. Myriad Case
Date:6/13/2013

Bethesda, MD, June 13, 2013: Today, the United States Supreme Court released its landmark decision in Association for Molecular Pathology et al. v. Myriad Genetics, Inc. et al. The Court unanimously agreed that "A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but cDNA is patentable because it is not naturally occurring."1

The decision helps to lay the foundation for continued research and application of diagnosis and treatment of diseases at the molecular level. "AMP applauds the U.S. Supreme Court on their ground breaking, unanimous decision. There is no question that this is a critical and right decision for the future of medicine and science. Biomedical researchers, clinicians, and most importantly patients will see great benefit from this development," said Jennifer L. Hunt, MD, MEd, AMP President.

In supporting AMP's position, the Court's detailed ruling noted, "In this case Myriad did not create anything. To be sure, it found an important and useful gene, but separating that gene from its surrounding genetic material is not an act of invention."2 "We believe the High Court today removed a significant barrier to innovation in molecular pathology testing," said Roger D. Klein, MD, JD, AMP Professional Relations Committee Chair," and we look forward to future advancements in clinical diagnostics and therapeutics that will accrue to the benefit of our patients and our field."


'/>"/>

Contact: Catherine Davidge
cdavidge@amp.org
301-634-7400
Association for Molecular Pathology
Source:Eurekalert

Page: 1

Related medicine news :

1. Pilates-in-the-Pines Celebrates 10 Year Anniversary by Offering Discounted Pilates Classes
2. SchizLife.com Celebrates 1-Year Anniversary, Debunks Harmful Schizophrenia Myths
3. First Choice Emergency Room Celebrates Spring, TX Community
4. Mount Sinai Celebrates ‘Team Science’ at Second-Annual SINAInnovations Conference Nov. 18-19, 2013
5. The Children’s Hospital of Philadelphia Celebrates the Birth of Its 1,000th Fetal Surgery Patient
6. Sola Salon Studios Celebrates Grand Opening
7. Document Management Solution Globodox by ITAZ Technologies, Celebrates World Environment Day
8. The Chris Elliott Fund Celebrates National Brain Tumor Awareness Month with Several New Education and Awareness Programs
9. SkilletsAndMore.Com Celebrates A FaceBook Page Mile Stone
10. Learning ZoneXpress Celebrates MyPlate's Birthday with New Active MyPlate Posters
11. Maryland University of Integrative Health Celebrates Commencement, Awards First Honorary Degree
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... ... wellness products to enhance people’s everyday lives, recently attended the January ECRM Trade ... , ATP Science is known for its large range of supplements that keep ...
(Date:1/20/2017)... ... ... Michael and Betsy Brauser celebrated 5 years of Betsy’s participation in a ... has been life-saving as she has been on the trial for more than six ... ovarian cancer in 2009. She underwent standard chemotherapy but a year later went to ...
(Date:1/20/2017)... ... 20, 2017 , ... Vitamin Well has launched two new ... have been produced in collaboration with Zlatan Ibrahimovic and have been developed to ... a successful launch in Sweden last year, the next generation sports drinks VW+001 ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “The Angel”: ... the Lord has set out for each of his children. “The Angel” is the ... School of Music in New York City, and impassioned writer. , When asked of ...
(Date:1/20/2017)... ... ... fine examination of how God handles sin, including how to let go of lingering guilt ... over ten long years has been waiting to release this powerful insight about forgiveness that ... serving the Lord for over twenty years, and he has been preaching and teaching the ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, Sympathomimetic-GABA ... drugs market is expected to grow at a CAGR of ... of 38.7% in the second half of the forecast period. The ... 2016 to 2027. The market is estimated at $1,058 million in ... ...
(Date:1/19/2017)... -- James Gilbart , ... 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ...      ... in a supplement to European Oncology & Haematology ... by James Gilbart and Axel ...
(Date:1/19/2017)... , Jan. 19, 2017   Science Exchange , ... to announce that the first five replication studies ... have been published in eLife today. Despite intense ... the first practical evaluation of reproducibility rates that ... studies. Unlike other assessments of reproducibility, the results ...
Breaking Medicine Technology: